WebJul 1, 2024 · Diversey Consulting; INDUSTRY SECTORS. Facility Management; Retail; Life Sciences; Healthcare; Food Service; Hospitality; Commercial Laundry; Government; … WebMay 10, 2024 · Diversey Announces First Quarter 2024 Results; Reaffirms Full Year Revenue And Adjusted EBITDA Guidance May 10, 2024 Reported sales +4.5% compared to prior year; Acquisition adjusted constant currency +7.0% Food and Beverage reported sales +14.8% compared to prior year Institutional reported sales +0.9% compared to …
775 W Diversey Pkwy APT 2FS, Chicago, IL 60614 Zillow
WebDiversey Holdings Ltd (DSEY) Stock Price & News - Google Finance Home DSEY • NASDAQ Diversey Holdings Ltd Follow Share $8.09 After Hours: $8.09 (0.00%) 0.00 Closed: Mar 31, 6:00:00 PM GMT-4... WebMar 17, 2024 · Diversey : Merger Agreement - Form 8-K. •Reported sales +4.3% in the fourth quarter compared to prior year and full year 2024 reported sales +5.6%. •Net loss of $59.5 million for the fourth quarter and $169.3 million for full year 2024. Fourth quarter Adjusted EBITDA was $93.4 million, representing Adjusted EBITDA margin of 13.3%. qk arrowhead\u0027s
1025 Diversey Dr, Saint Louis, MO 63126 MLS #23019508 Zillow
WebApr 14, 2024 · Diversey Holdings, Ltd. (NASDAQ:DSEY - Get Rating) has been given a consensus recommendation of "Hold" by the twelve brokerages that are currently covering the firm, MarketBeat.com reports.One investment analyst has rated the stock with a sell rating and eleven have issued a hold rating on the company. The average 1 year price … WebApr 20, 2024 · FORT MILL, S.C., April 20, 2024 (GLOBE NEWSWIRE) -- Diversey Holdings, Ltd. (NASDAQ: DSEY) has appointed Selim Bassoul and Juan R. Figuereo to the company’s board of directors, effective March 25, 2024, following the public listing. Mr. Bassoul will serve as chairman of Diversey’s board. These appointments will bring the … WebMar 9, 2024 · FORT MILL, S.C., March 09, 2024 (GLOBE NEWSWIRE) -- Diversey Holdings, Ltd. ("Diversey") (NASDAQ: DSEY) announced fourth quarter and full year results with continued top line growth and margin expansion. Net loss attributable to common stockholders was $35.7 million for the fourth quarter and $174.8 million for full-year 2024 qk anesthesia